Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00318708 · ClinicalTrials.gov registry record · Phase 3

Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)

A Phase 3 study of Asthma, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
Phase 3
Development phase
92
Enrollment target
10
Study locations

NCT00318708 is a Phase 3 study of Asthma that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 92 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (94% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00318708, a Phase 3 study of Asthma, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
Phase 3
Development phase
92 participants
Enrollment target
10
Study locations

Study Summary

Asthma can be caused by a variety of factors, including tobacco smoke, allergens, and respiratory airway infections. Many people use inhaled corticosteroid medications to treat their symptoms. These medications, however, are not effective for everyone. Clarithromycin is an antibiotic that may effectively treat asthma in these individuals. This study will evaluate the effectiveness of clarithromycin at controlling asthma symptoms.

Conditions Studied

Asthma

Interventions

  • DRUG fluticasone propionate
  • DRUG clarithromycin
  • DRUG placebo clarithromycin

Study Locations (10)

California

  • University of California, San Diego - San Diego
  • University of California, San Francisco - San Francisco

North Carolina

  • Duke University Medical Center - Durham
  • Wake Forest University Health Sciences - Winston-Salem

Colorado

  • National Jewish Medical and Research Center - Denver

Massachusetts

  • Brigham & Women's Hospital - Boston

Missouri

  • Washington University, St. Louis - St Louis

New York

  • Columbia University Medical Center - New York

Texas

  • University of Texas Medical Branch - Galveston

Wisconsin

  • University of Wisconsin, Madison - Madison

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2006-06
Est. Completion 2009-04
Phase Phase 3

Sponsor

Milton S. Hershey Medical Center

396 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00318708

The ClinicalTrials.gov registry entry for NCT00318708 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 92 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (94% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 3 interventions - of which fluticasone propionate is the first listed.

NCT00318708 reports 10 study locations spanning 8 distinct geographic areas - top geographies include California, North Carolina, Colorado.

Frequently Asked Questions

What is clinical trial NCT00318708 about?

NCT00318708 is a clinical study titled "Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA)". Asthma can be caused by a variety of factors, including tobacco smoke, allergens, and respiratory airway infections. Many people use inhaled corticosteroid medications to treat their symptoms. These medications, however, are not effective for everyone. Clarithromycin is an antibiotic that may effect...

What is the current status of trial NCT00318708?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 92 participants. The study started on 2006-06. Estimated completion is 2009-04.

What conditions does trial NCT00318708 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT00318708?

The interventions under investigation include: fluticasone propionate (DRUG), clarithromycin (DRUG), placebo clarithromycin (DRUG).

Who is sponsoring clinical trial NCT00318708?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00318708 being conducted?

This trial has 10 study locations across California, Colorado, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.